Come dance with us at Association of Women in Rheumatology 2025 back at the Gaylord Palms near Orlando.

Cheers to the future of rheumatology! Association of Women in Rheumatology

Drs. LianneGensler and Catherine Bakewell bring down the house Association of Women in Rheumatology discussing pregnancy in rheum pts. One of my takeaways: Don’t use NSAIDs in these pts if you can avoid them. They may decrease implantation (some data in animals models) so discuss family planning with

What a team! What a conference! Association of Women in Rheumatology

Rct of > 200 patients with knee OA treated with usual care plus mtx vs pbo. Mtx titrated to 25mg weekly and showed improvement in pain score c/w PBO at 6 months w/o significant AEs! Tuhina Neogi, MD, PhD AM Malfait —will this change OA management?

Why is it important to incorporate patient reported outcomes (PROs) into clinical trials? Because the intervention is for the patient, and we need to know what matters most to them. - Dr M Jolly Una Makris

An amazing night in Chicago celebrating Dr. Bing Chang at the Arthritis Foundation Freedom of Movent gala. Dr. Chang was inspirational in my decision to join #rheumatology and it was such a fun treat to surprise him last night. Also great to see Cuoghi Edens. She remains a passionate and

ACR fun with friends!

The best part of #ACR2024 remains the people!

Interesting! Study of pts w/ ANA(-) & dsDNA(+). 1 in 5 dx with APLS! Have others seen that? I have been disgregarding this pattern, though some of that is related to my in-house assay (seems overly-sensitive) & my bias against overdiagnosis #ACR24 Dr. John Cush Abstr#2391

A wonderful blessing to start #rwcs 2025

I lost my crystal ball (confession, I’m not sure I ever had one) but determining which patients may progress to RA is very difficult/important. Drs Dr. John Cush and Kavanaugh RWCS reviewed potential predictive model from #EULAR2024 1. Hand/foot joint tenderness 2. AM stiffness

Mayo clinic long term study of pts dx with seronegative RA showed 15% changed dx (mostly SpA, seropositive RA,) nearly 30% were in drug free remission, and 15% were on b/tsDMARDs at 10 years. Similar results supported from other studies. Highlights consideration for

Heard of the “3 S” rule describing risk factors for developing ILD in RA pts? 1. Smoking 2. Seropositive 3. Sex (male) Remember these when evaluating your patients Dr. John Cush RWCS #RWCS2025

Hey #rheumatology are you prescribing GLP-1s in your practice? RWCS Dr. John Cush

A potential creative way to alleviate the rheumatology shortage. AI vs rheumatologist US evaluation similar. This is a first iteration but expect more info. RWCS Dr. John Cush #RWCS2025

What does it take to achieve true precision medicine in rheumatology? We need genomic, transcriptomic, proteomic, metabolomic, and immune phenotypic archtyping. Dr. Tanaka RWCS #RWCS2025

“You can see extra-cranial vessel disease in LVV in up to 80% of patients.” Anisha Dua reminds us to get non-invasive imaging in all newly diagnosed LVV pts. #rwcs2025 Dr. John Cush RWCS

Remember to check the temporal, axillary, carotid, and subclavian arteries for possible halo sign with US in vasculitis. Additional data suggests getting US early (within 4 days of starting steroids) if possible, as halo sign declines after GC exposure. Anisha Dua Dr. John Cush

How do you screen your SSc patients for ILD? HRCT is the optimal screening tool over PFTs and XR. Dr. Elizabeth Volkmann Dr. John Cush RWCS #rwcs2025